Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Censoring Survival Data01:09

Censoring Survival Data

626
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
626
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

473
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
473
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

687
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
687
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

687
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
687
Truncation in Survival Analysis01:09

Truncation in Survival Analysis

679
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
679
Randomized Experiments01:13

Randomized Experiments

9.2K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
9.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Developing Machine Learning-Based Predictive Models for Hallux Valgus Recurrence Based on Measurements From Radiographs.

Foot & ankle international·2024
Same author

Diverse functions and pathogenetic role of Crumbs in retinopathy.

Cell communication and signaling : CCS·2024
Same author

Enhancing Global Estimation of Fine Particulate Matter Concentrations by Including Geophysical <i>a Priori</i> Information in Deep Learning.

ACS ES&T air·2024
Same author

Macrophage membrane-coated nanoparticles for the treatment of infectious diseases.

Biomedical materials (Bristol, England)·2024
Same author

Study on the secondary oxidation behavior and microscopic characteristics of oxidized coal gangue.

Environmental science and pollution research international·2024
Same author

Delaying the first nucleation event of amorphous solid dispersions above the polymer overlap concentration (c*): PVP and PVPVA in posaconazole.

Journal of pharmaceutical sciences·2024
Same journal

Fast penalized generalized estimating equations for large longitudinal functional datasets.

Biometrics·2026
Same journal

Causally-interpretable random-effects meta-analysis.

Biometrics·2026
Same journal

Statistical inference for mean function of partially observed functional time series.

Biometrics·2026
Same journal

Subgroup identification via Interaction Tree and Mixed Model for Repeated Measures with application to Alzheimer's disease.

Biometrics·2026
Same journal

Finite mixtures of linear quantile regressions with concomitant variables: a solution to endogeneity in longitudinal data modeling.

Biometrics·2026
Same journal

Discussion on "INTACT: a method for integration of longitudinal physical activity data from multiple sources" by Jingru Zhang, Erjia Cui, Hongzhe Li, and Haochang Shou.

Biometrics·2026
See all related articles

Related Experiment Video

Updated: Mar 13, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.4K

Inference in randomized trials with death and missingness.

Chenguang Wang1, Daniel O Scharfstein2, Elizabeth Colantuoni2

  • 1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, U.S.A.

Biometrics
|October 19, 2016
PubMed
Summary
This summary is machine-generated.

This study introduces a new method to compare treatments in clinical trials by combining functional outcomes and survival data. This approach properly handles missing data, preventing biased results in severely ill patient populations.

Keywords:
Composite endpointDeath-truncated dataMissing dataSensitivity analysis

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.0K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K

Related Experiment Videos

Last Updated: Mar 13, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.4K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.0K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K

Area of Science:

  • Clinical Trials Methodology
  • Biostatistics
  • Health Outcomes Research

Background:

  • Missing functional outcomes in severely ill patients can bias treatment comparisons.
  • Unobserved data due to missed visits, withdrawal, or death is a common challenge.

Purpose of the Study:

  • To propose a novel procedure for treatment comparison using a composite endpoint.
  • To address unobserved functional outcomes in clinical trials, particularly when death is a factor.
  • To introduce a missing data imputation scheme and sensitivity analysis.

Main Methods:

  • Development of a composite endpoint combining functional outcome and survival data.
  • Implementation of a missing data imputation strategy for unobserved outcomes not due to death.
  • Application of sensitivity analysis to assess the robustness of results.

Main Results:

  • The proposed method was illustrated using data from non-small cell lung cancer and sedation interruption trials.
  • The composite endpoint approach effectively integrates survival and functional data.
  • The imputation and sensitivity analyses provide reliable handling of missing data.

Conclusions:

  • The proposed composite endpoint and missing data methods offer a robust approach for treatment comparisons in clinical trials.
  • This methodology helps mitigate bias caused by unobserved functional outcomes in severely ill patients.
  • Accurate treatment effect estimation is improved by accounting for both survival and functional status.